Tag Archive for cancer

Israeli researchers develop ‘cluster bomb’ pill to eradicate leukemic proteins

Being developed for oral use, not an injection, the ground-breaking treatment for acute myeloid leukemia will accomplish the work of 3-4 separate drugs, reduce cancer patients’ need for radical procedures and eliminate some unbearable side effects.
• The Hebrew University of Jerusalem researchers are  trying to expand the drug’s use to other cancers.

By Ran Reznick, Erez Linn, Maytal Yasur Beit-Or & Israel Hayom Staff

 

Researchers at the Hebrew University of Jerusalem have recently developed a breakthrough biological drug to treat people suffering from acute myeloid leukemia.

AML is one of the most aggressive cancers, and while other cancers have benefited from new treatments, there has been little encouraging news for most leukemia patients for the past 40 years, the researchers said in a statement. Continue Reading »

FDA approves Israeli-developed, personally tailored cancer-killer drug

Developed by researchers at Israel’s Weizmann Institute and Sourasky Medical Center, the U.S. Food and Drug Administration fast-tracked the approval for their cancer treatment Yescarta, based on technology that uses the patient’s immune system to destroy cancer cells.
• List price in U.S. for the personally tailored drug is $373,000.

By Hezi Sternlicht & Israel Hayom Staff

 

Kite Pharma, founded by Israeli-American Professor Arie Belldegrun in 2009, has announced that the U.S. Food and Drug Administration has granted regular approval for its cancer treatment Yescarta.

California-based Gilead Sciences bought Kite Pharma for $12 billion in August this year.

Professor Arie Belldegrun – Photo: Kite Pharma

The product, which was approved on a fast-track process, is based on innovative technology that recruits the body’s immune system to identify and destroy cancer cells. Continue Reading »

Syrian schoolgirl returns home after being cured of blood cancer in Israel

 

view videoWith the help of the Israeli gov’t, the IDF tracked down her family in Syria and covertly spirited her brother to Israel, so a bone-marrow transplant at Rambam Hospital was able to cure her cancer.

 

A six-year-old girl from Syria who was treated for her wound and a blood disease at Haifa’s Rambam Medical Center was discharged and sent home on Tuesday after her new Israeli friends held a farewell party and gave her with many gifts, including a first-grade backpack — in the hope that her school is still standing.

Photo Rambam Hospital

She was one of the 140 Syrian civilians — men, women and children — that Rambam doctors, nurses and other personnel have treated over the past three years of civil war there. Continue Reading »

Israel develops revolutionary prostate cancer treatment at Weizmann Institute

 

Prof. Avigdor Scherz & Prof. Yoram Salomon of the Weizmann Institute develop a groundbreaking treatment for prostate cancer patients that targets the tumor without damaging genitalia, urinary tract, or general quality of life.

By Rotem Elizera

 

The incidence of prostate cancer, especially among men, in Israel has increased in the past two decades. However, Professor Avigdor Scherz and Professor Yoram Salomon of the Weizmann Institute have developed a groundbreaking treatment, bearing good news for the patients diagnosed with the deadly disease.

Special prostate cancer treatment. – Photo: Yariv Katz

Prostate cancer patients face a dilemma today: Undergoing prostate surgery and radiation, which often causes erectile dysfunction and urinary retention, or staying under “active surveillance,” which could allow the cancer to metastasize. Continue Reading »

Israeli earns int’l honors for discovery that diagnoses cancer by sensing breath

 

Israeli professor from the Technion  said, “Precisely because I am not a doctor, I was able to conceive such a unique development – an inexpensive & noninvasive system for diagnosing diseases based on breath.”

 

Prof. Hossam Haick of Haifa’s Technion-Israel Institute of Technology received the Humboldt Research Award in Germany and was also chosen as one of the 100 influential figures published by California’s Good Magazine over the weekend. He has been prominent, among other things in his development of devices to diagnose and monitor various types of cancers (lung, breast, colon, gastric, head and neck, ovarian, kidney and bladder malignancies) via breath samples. Continue Reading »

Hebrew University of Jerusalem develops blood-test to find diabetes, multiple sclerosis, cancers

Israel’s groundbreaking new blood test, still in early stages, could save countless lives by detecting diseases such as pancreatic cancer, pancreatitis, diabetes, traumatic brain injury & multiple sclerosis early on.

By Arutz Sheva Staff

 

An experimental blood test may one day be able to detect a range of diseases including cancer and multiple sclerosis, based on signatures of DNA from dying cells, researchers said Monday.

Blood test (illustration) – iStock

The work, described in the Proceedings of the National Academy of Sciences, a peer-reviewed US journal, is still in its early stages, but opens up vast possibilities, the study authors said.
Continue Reading »

Israeli Cancer Cure Brings Amazing Results in American Tests

 

Innovative Israeli cure shows 94% of leukemia patients in clinical test in the U.S. exhibits signs of recovery.

By Israel Today Staff

 

An innovative Israeli-developed cure for leukemia that is currently being tested in the US is seeing amazing results.

The clinical tests have been run primarily on patients with advanced leukemia that were given only a matter of months to live. An astonishing 94 percent have reportedly shown improvement, and in more than half symptoms related to the cancer have disappeared all together.

Professor Zelig Eshhar

Professor Stanley Riddell of the University of Washington, who is running the tests, cautioned that much work remains to clarify the results of the study, and it is still unknown if the treatment managed to remove the cancer completely, or if it will return in the aforementioned patients. Continue Reading »

Israeli cancer treatment company raises $12m for lymphoma trials

 

The Jerusalem-based cancer treatment company, KAHR Medical, recently received regulatory approval to initiate a Phase-I/IIa trial in lymphoma treatment.

By Globes Staff

 

cancer – illustrative

Proceeds of the new financing will be used primarily to fund the clinical development of KAHR’s lead product, KAHR-102, which recently received regulatory approval in Israel to initiate a Phase-I/IIa trial in lymphoma, as well as pre-clinical development of KAHR-101 and new pipeline programs.Korea Investment Partners, Mirae Asset Venture Investment and DSC Investment, participated in the first closing, along with an existing investor, Flerie Invest AB, a company controlled by Thomas Eldered, CEO and a major shareholder in Recipharm (RECI-B.ST), one of the largest pharmaceutical Contract Development and Manufacturing Organizations (CDMO) in Europe.
Continue Reading »

Israeli micro-antenna will revolutionize treatment of small tumors

Hebrew University of Jerusalem students are working on micro-antenna that can be inserted into the stomach to detect & treat cancers too small to be treated with available methods.

By Yori Yalon

 

Students at the Hebrew University in Jerusalem are developing an innovative micro-antenna able to focus radiation at tiny tumors in the digestive tract.

An image of the innovative new antenna, which will revolutionize treatment of small tumors

Israeli doctors develops new noninvasive procedure for early detection of colon cancer

Doctors at Maccabi Health Services have developed a simple blood test for early detection of Israel’s 2nd-deadliest cancer, to replace the previous unpleasant procedures of colonoscopies & collecting stool samples.

 

Maccabi Health Services has developed a new noninvasive procedure to detect early signs of colon cancer.

Doctors hope new noninvasive technique to determine signs of colon cancer will lead many people to get tested who avoided the uncomfortable tests previously offered – Photo: Liquidlibrary

Colon cancer is the second most common and deadly form of cancer in Israel, with 3,200 new cases diagnosed and 1,300 deaths resulting from it in 2012. Continue Reading »

CANCER BREAKTHROUGH: Israeli Nobel Prize winner leads team to discovery

By i24news

 

A new study by Israeli researchers at the Israel Institute of Technology’s cancer research center could prove to be “most significant” in controlling the growth of cancer cells, Israeli media reported on Sunday.

Scientists will sequence the genetic codes of about 75,000 patients with cancer and rare diseases – Photo: Leon Neal/AFP/File

A team of Israeli researchers at the Technion’s Rappaport Faculty of Medicine, headed by Prof. Aaron Ciechanover, an Israeli Nobel Prize winner in chemistry, and led by Dr.

Continue Reading »

Israeli Cancer Vaccine Initiates Favorable Reaction In 90% Of Cancer Types

 

Video icon JPEG WATCH: An Israeli biotechnology company has developed a vaccine for cancer, which is not designed to treat the illness – but to attack and kill the cells preventing it from returning.

By Jonathan Neff, NoCamels.com

 

There’s no doubt that cancer is one of the world’s most vicious diseases. For decades, scientists have been trying to find a cure for cancer, a terminal illness that kills 8 million people worldwide every year. With 14 million new cancer cases diagnosed around the globe every year, according to the World Health Organization, the need for prevention is vital. Now, an Israeli biotechnology company is developing a vaccine for cancer, which is not designed to treat the disease – but to prevent it from returning. Continue Reading »

Jerusalem’s Hadassah Hospital discovery may help detect colon & uterine cancers early

 

A senior oncologist at Hadassah Hospital says the study finds it is possible to identify a genetic mutation that raises the chances of suffering from colon or uterine cancers, allowing the prevention and/or early treatment of the cancers.

Israeli scientists: Treat cancer at night

Medical researchers at Israel’s Weizmann Institute of Science find timing may be everything, in eliminating the spread of tumors.

 

They emerge at night, while we sleep unaware, growing and spreading out as quickly as they can. And they are deadly.

Lab mouse

A lab mouse in New York. The mice in the Weizmann study did better when receiving the cancer drug at night. – Photo: Bloomberg

It turns out tumors spread faster at night time, Weizmann Institute of Science researchers showed in findings recently published in Nature Communications, suggesting that it would be better to deliver cancer treatments in the wee hours of the night.

Continue Reading »

Revolutionary Israeli treatment facilitates cancer patients’ bodies to heal themselves

Meet Keytruda, the Israeli drug for fighting metastatic melanoma. If this new treatment known as immunotherapy lives up to expectations, the world of oncology will undergo a real treatment revolution within just a few years.

By Sarit Rosenblum

 

At the age of 68, Prof. Ben-Shabbat noticed an odd-looking sore on his head. “They told me at the hospital that it’s a melanoma and needs to be surgically removed,” he relates. “After the operation, I said to myself, thank God it’s gone.” But the sore reappeared, on his neck this time. The doctors informed Ben-Shabbat and his family that they were dealing with a metastatic growth, and that Ben-Shabbat’s future looked bleak. Continue Reading »